Véronique Gelsi‐Boyer

Mutations of polycomb‐associated gene <i>ASXL1</i> in myelodysplastic syndromes and chronic myelomonocytic leukaemia

Véronique Gelsi‐Boyer, Virginie Trouplin, José Adélaı̈de et al. · British Journal of Haematology · 2009 · 555 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Genetics +19

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Raphaël Itzykson, Olivier Kosmider, Aline Renneville et al. · Journal of Clinical Oncology · 2013 · 537 citations

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Raphaël Itzykson, Olivier Kosmider, Thomas Cluzeau et al. · Leukemia · 2011 · 464 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al. · Blood · 2009 · 269 citations

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Olivier Kosmider, Véronique Gelsi‐Boyer, Marion Ciudad et al. · Haematologica · 2009 · 241 citations · Full text